Peptide Self-Assembly

Overview

Peptide self-assembly describes the spontaneous organization of short peptide building blocks into ordered supramolecular architectures through non-covalent interactions including hydrogen bonding, electrostatic attraction, hydrophobic effects, and π-π stacking. The emergent structures span diverse morphologies—nanofibers, nanotubes, vesicles, sheets, and hydrogels—with dimensions ranging from nanometers to micrometers. This bottom-up fabrication approach has generated significant interest in biomedical applications, particularly in tissue engineering, drug delivery, and regenerative medicine.

Molecular Determinants of Self-Assembly

The tendency of a peptide to self-assemble is governed by its physicochemical properties, particularly the balance between hydrophobic and hydrophilic residues, net charge, and secondary structure propensity. Peptides with alternating hydrophobic-hydrophilic patterns favor β-sheet formation, which propagates into two-dimensional nanosheets or one-dimensional nanofibers through intermolecular backbone hydrogen bonding. Amphiphilic peptides with a hydrophobic segment exceeding five residues in length tend to form micelles or vesicles above a critical aggregation concentration. Charged residues at terminal positions provide electrostatic repulsion that prevents uncontrolled aggregation, while pH-sensitive residues (histidine, glutamate, aspartate) enable stimuli-responsive assembly and disassembly.

Peptide Amphiphiles

Peptide amphiphiles (PAs) are a particularly versatile class of self-assembling molecules consisting of a hydrophobic alkyl tail covalently attached to a hydrophilic peptide sequence. The archetypal PA structure includes an alkyl chain (typically C12–C16) connected to a peptide containing β-sheet-forming valine or alanine residues, charged residues for solubility, and a bioactive epitope at the C-terminus. In aqueous solution, PAs self-assemble into cylindrical nanofibers approximately 6–8 nm in diameter and micrometers in length, with the hydrophobic tails sequestered in the fiber core and the peptide epitopes displayed on the surface. The Stupp group demonstrated that PA nanofibers incorporating the IKVAV laminin epitope promote neurite outgrowth and spinal cord regeneration in animal models.

Hydrogel Formation

Peptide-based hydrogels are formed when self-assembling peptide networks trap water through capillary forces within an entangled nanofiber mesh. The resulting materials exhibit viscoelastic properties suitable for injectable delivery, with storage moduli (G’) ranging from 10 to 10,000 Pa depending on peptide concentration and assembly conditions. Several peptide hydrogel systems have entered clinical development, including RADA16-I (PuraStat), which forms β-sheet nanofibers upon exposure to physiological ionic strength and achieves hemostatic action through platelet activation. Peptide hydrogels offer distinct advantages over polymeric hydrogels including biodegradability, absence of chemical crosslinking toxicity, and capacity for cellular infiltration through the nanofiber network.

Applications in Tissue Engineering

The capacity of self-assembling peptides to present bioactive signals in a three-dimensional extracellular matrix-mimetic environment makes them attractive scaffolds for tissue engineering. PA hydrogels incorporating the IKVAV epitope restore neuronal tissue in spinal cord injury models, while mineralizing PA nanofibers containing phosphoserine residues promote bone regeneration. Cardiac repair applications employ PA nanofibers displaying the heptapeptide FHRRIKA, which promotes angiogenesis and reduces infarct size in rodent models. The modularity of PA design allows combinatorial presentation of multiple bioactive epitopes with precisely controlled stoichiometry.

Conclusion

Peptide self-assembly provides a programmable platform for creating functional biomaterials with nanoscale precision. Continued advances in computational design, sequence optimization, and scalable manufacturing are expanding the translational potential of self-assembling peptide systems toward clinical applications.